Pernod Ricard stock (FR0000130577): Faces competition probe in India
11.05.2026 - 15:28:51 | ad-hoc-news.dePernod Ricard S.A. is facing a competition investigation in India, where the Competition Commission of India (CCI) raided its offices in December 2024 over allegations of bid rigging, cartel conduct, and exclusive retail deals. The probe involves Pernod Ricard and seven other liquor companies, according to Just Drinks as of December 2024 and MLex as of 2024. India represented 13% of Pernod Ricard's €10.96 billion net sales in its 2024/2025 financial year, highlighting the market's importance.
As of: 11.05.2026
By the editorial team – specialized in equity coverage.
At a glance
- Name: Pernod Ricard S.A.
- Sector/industry: Beverages - Wine & Spirits
- Headquarters/country: France
- Core markets: Europe, Americas, Asia, India
- Key revenue drivers: Premium spirits brands like Absolut, Jameson, Chivas Regal
- Home exchange/listing venue: Euronext Paris (RI)
- Trading currency: EUR
Official source
For first-hand information on Pernod Ricard, visit the company’s official website.
Go to the official websitePernod Ricard: core business model
Pernod Ricard S.A. is a leading global spirits and wine producer, with a portfolio of over 240 premium brands sold in more than 160 countries. The company focuses on high-end products including vodka (Absolut), whiskey (Jameson, Chivas Regal), cognac (Hennessy via joint venture), and champagne (Perrier-Jouët, G.H. Mumm). Its business model emphasizes brand investment, marketing, and distribution through a network of subsidiaries and joint ventures.
Revenue is driven by organic growth, acquisitions, and premiumization trends. In the 2024/2025 fiscal year, net sales reached €10.96 billion, per company reports cited in recent coverage. Pernod Ricard lists primarily on Euronext Paris, with significant US investor interest due to its exposure to the world's largest spirits market.
Main revenue and product drivers for Pernod Ricard
Key drivers include flagship brands like Jameson (world's top Irish whiskey), Absolut Vodka, and The Glenlivet single malt. India, a high-growth market, contributed 13% of FY 2024/2025 net sales (€1.42 billion equivalent), fueled by rising premium alcohol demand. Other regions like the US and Europe provide stable contributions, with premium whiskies and vodkas leading growth.
Strategic priorities include sustainability initiatives and digital sales channels, alongside expansion in emerging markets. The India investigation underscores regulatory risks in fast-growing regions critical to revenue diversification.
Industry trends and competitive position
The global spirits industry faces premiumization, health trends shifting to low/no-alcohol options, and regulatory scrutiny on pricing and distribution. Pernod Ricard competes with Diageo, Constellation Brands, and Brown-Forman, holding a strong No. 2 position behind Diageo. Its focus on owned brands (versus distributed) supports margins amid cost inflation.
In the US, Pernod Ricard benefits from robust whiskey demand, with brands like Jameson gaining shelf space. US investors track its performance for insights into consumer spending on luxury goods.
Why Pernod Ricard matters for US investors
Pernod Ricard offers US investors exposure to global premiumization without direct US domicile, trading as an ADR (PDRDY) over-the-counter. Its US market sales, driven by popular imports, tie into American consumer trends. The India probe highlights emerging market risks but also growth potential in a sector relevant to US portfolios.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Conclusion
The ongoing CCI investigation in India spotlights regulatory challenges for Pernod Ricard in a vital growth market representing 13% of sales. While the company maintains a robust portfolio and global footprint, investors monitor outcomes for potential impacts on operations and sentiment. Developments will be key as Pernod Ricard navigates competition and expansion.
Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.
So schätzen die Börsenprofis Publicis Aktien ein!
Für. Immer. Kostenlos.
